Delivery Order SPE2DB24D2213-SPE2DB25FGVEY

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,567.70 firm fixed-price delivery order contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 9, 2025 and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,344.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 11, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $24,385.52 firm fixed-price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of August 18, 2022 and was awarded on August 17, 2022. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award, valued at $6,948.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to manage type 2 diabetes. This is a Firm Fixed Price Delivery Order contract with a completion date of May 26, 2023. The award is not associated with a set-aside program, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,455.28 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a completion date of December 23, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,266.66 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 9, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,743.00 firm-fixed-price delivery order contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has a period of performance through December 12, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Januvia 100 mg tablets, a medication used to treat diabetes. The contract is a firm fixed-price arrangement with a completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $6,208.59, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the delivery of Januvia 100mg tablets, a medication used to treat type 2 diabetes. The contract has a period of performance through November 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
  • SPE2DB24D2213
    Indefinite Delivery Contract
  • SPE2DB24D2213-SPE2DB25FGVEY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,948.00 firm fixed-price delivery order contract is for the provision of 90-count tablets of Januvia 100mg, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 4, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/31/25, 9:20 AM